Findings from this multicenter randomized controlled trial showed that the transition bundle was associated with a lower risk of 7-day and 30-day hospital readmission from chronic obstructive pulmonary disease (COPD).
Real-world findings indicate that a transition bundle for hospitalized patients with chronic obstructive pulmonary disease (COPD) lowers their chance of being readmitted to the hospital within a month of discharge, and that connecting the patient with a care coordinator has a limited impact on outcomes, according to the study published in Chest.
Findings from the multicenter randomized controlled trial of 4000 patients show that compared with patients not receiving the intervention, patients who received the transition bundle were 83% (relative risk [RR], 0.17; 95% CI, 0.07-0.35) less likely to be readmitted to the hospital within 7 days of discharge and were 26% (RR, 0.74; 95% CI, 0.60-0.91) less likely to be readmitted to the hospital within 30 days of discharge. Readmissions within 90 days were not different between the groups.
The transition bundle included:
“Individuals living with COPD experience disproportionately high hospital (re)admission rates and longer hospital length of stay (LOS), resulting in increased costs and significant variability in the care provided,” explained the researchers. “Variability in care contributes to suboptimal care transitions, increased (re)admissions and (re)visits, and poor health outcomes. Minimizing care variability and improving coordination across the care continuum may lower the frequency of COPD hospital readmissions and ED [emergency department] revisits while improving quality and continuity of care.”
One proposed solution to these challenges has been care bundles, explained the researchers, noting that the variable results of the approach have been documented. However, in the current study, the researchers found that uptake of the transition bundle was low, 19.2%, across sites.
Compared with patients who did not receive the intervention, patients who received the transition bundle had a 7.3% (RR, 1.07; 95% CI, 1.0-1.15) relative increase in median LOS and a 76% (RR, 1.76; 95% CI, 1.53-2.02) increased risk of a 30-day hospital revisit. They were also more likely to follow up with their family physician within 14 days of hospital discharge.
“The transition bundle group visited the ED on average 2.4 times per patient within 30 days of discharge compared with 1.3 times per patient in the usual care group. The same group who made increased ED visits within 30 days also showed a significantly lower rate of 30-day hospital readmissions,” noted the researchers. “Aboumatar et al attribute an increased frequency of ED visits among patients with COPD to greater symptom awareness, which may explain the current findings, given that our transition bundle contained COPD education components including symptom awareness.”
The researchers assessed the impact of adding a care coordinator to the transition bundle, finding that it had no impact on hospital readmissions at any point, median LOS, or 30-day hospital revisits. However, the care coordinator was associated with a 7.6% increase in follow up with the family physician within 14 days and this occurred 2.4 days sooner compared with patients not connected with a care coordinator. This finding, said the researchers, indicate that the transition bundle promoted interaction with primary care, which could have contributed to the lower readmissions seen among patients receiving the intervention.
Reference
Atwood C, Bhutani M, Ospina M, et al. Optimizing COPD acute care patient outcomes using a standardized transition bundle and care coordinator: a randomized controlled trial. Chest. 2022;162(2):321-330. doi:10.1016/j.chest.2022.03.047
Medicaid Budget Survey Highlights Postpandemic Challenges and Priorities
October 24th 2024The Medicaid budget survey for fiscal years 2024 and 2025 revealed state predictions are expecting a decline in Medicaid enrollment and an increase in spending next year due to the end of pandemic-era policies and federal funding.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Breast Cancer Outcomes Improved in States With Medicaid Expansion
October 24th 2024Medicaid expansion is associated with improved care and increased survival rates for patients with certain breast cancers, but future studies should focus on whether Medicaid expansion mitigates the disparities between Black and non-White patients.
Read More
Etonogestrel Contraceptive Implants Reduce Pain Crises in Women With Sickle Cell Disease
October 23rd 2024Etonogestrel-releasing contraceptive implants in women with sickle cell disease significantly reduced pain intensity and frequency of pain crises over 12 months, with no adverse changes in metabolic or liver function markers.
Read More